Genome-wide screening for understanding the role of DNA methylation in colorectal cancer

F. Sípos, G. Müzes, Árpád V. Patai, István Fũri, Bálint Péterfia, Péter Hollósi, B. Molnár, Z. Tulassay

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

DNA methylation analysis methods have undergone an impressive revolution over the past 15 years. Regarding colorectal cancer (CRC), the localization and distribution of several differently methylated genes have been determined by genome-wide DNA methylation assays. These genes do not just influence the pathogenesis of CRC, but can be used further as diagnostic or prognostic markers. Moreover, the identified four DNA methylation-based subgroups of CRC have important clinical and therapeutic merit. Since genome-wide DNA methylation analyzes result in a large amount of data, there is a need for complex bioinformatic and pathway analysis. Future challenges in epigenetic alterations of CRC include the demand for comprehensive identification and experimental validation of gene abnormalities. By introduction of genome-wide DNA methylation profiling into clinical practice not only the patients' risk stratification but development of targeted therapies will also be possible.

Original languageEnglish
Pages (from-to)569-581
Number of pages13
JournalEpigenomics
Volume5
Issue number5
DOIs
Publication statusPublished - Oct 2013

Fingerprint

DNA Methylation
Colorectal Neoplasms
Genome
Genes
DNA Fingerprinting
Computational Biology
Epigenomics
Therapeutics

Keywords

  • bisulfite treatment
  • colorectal cancer
  • epigenetics
  • genome-wide DNA methylation
  • next-generation sequencing

ASJC Scopus subject areas

  • Genetics
  • Cancer Research

Cite this

Genome-wide screening for understanding the role of DNA methylation in colorectal cancer. / Sípos, F.; Müzes, G.; Patai, Árpád V.; Fũri, István; Péterfia, Bálint; Hollósi, Péter; Molnár, B.; Tulassay, Z.

In: Epigenomics, Vol. 5, No. 5, 10.2013, p. 569-581.

Research output: Contribution to journalArticle

Sípos, F. ; Müzes, G. ; Patai, Árpád V. ; Fũri, István ; Péterfia, Bálint ; Hollósi, Péter ; Molnár, B. ; Tulassay, Z. / Genome-wide screening for understanding the role of DNA methylation in colorectal cancer. In: Epigenomics. 2013 ; Vol. 5, No. 5. pp. 569-581.
@article{0f24556f1b4c4d6696fec9cf6868f074,
title = "Genome-wide screening for understanding the role of DNA methylation in colorectal cancer",
abstract = "DNA methylation analysis methods have undergone an impressive revolution over the past 15 years. Regarding colorectal cancer (CRC), the localization and distribution of several differently methylated genes have been determined by genome-wide DNA methylation assays. These genes do not just influence the pathogenesis of CRC, but can be used further as diagnostic or prognostic markers. Moreover, the identified four DNA methylation-based subgroups of CRC have important clinical and therapeutic merit. Since genome-wide DNA methylation analyzes result in a large amount of data, there is a need for complex bioinformatic and pathway analysis. Future challenges in epigenetic alterations of CRC include the demand for comprehensive identification and experimental validation of gene abnormalities. By introduction of genome-wide DNA methylation profiling into clinical practice not only the patients' risk stratification but development of targeted therapies will also be possible.",
keywords = "bisulfite treatment, colorectal cancer, epigenetics, genome-wide DNA methylation, next-generation sequencing",
author = "F. S{\'i}pos and G. M{\"u}zes and Patai, {{\'A}rp{\'a}d V.} and Istv{\'a}n Fũri and B{\'a}lint P{\'e}terfia and P{\'e}ter Holl{\'o}si and B. Moln{\'a}r and Z. Tulassay",
year = "2013",
month = "10",
doi = "10.2217/epi.13.52",
language = "English",
volume = "5",
pages = "569--581",
journal = "Epigenomics",
issn = "1750-1911",
publisher = "Future Medicine Ltd.",
number = "5",

}

TY - JOUR

T1 - Genome-wide screening for understanding the role of DNA methylation in colorectal cancer

AU - Sípos, F.

AU - Müzes, G.

AU - Patai, Árpád V.

AU - Fũri, István

AU - Péterfia, Bálint

AU - Hollósi, Péter

AU - Molnár, B.

AU - Tulassay, Z.

PY - 2013/10

Y1 - 2013/10

N2 - DNA methylation analysis methods have undergone an impressive revolution over the past 15 years. Regarding colorectal cancer (CRC), the localization and distribution of several differently methylated genes have been determined by genome-wide DNA methylation assays. These genes do not just influence the pathogenesis of CRC, but can be used further as diagnostic or prognostic markers. Moreover, the identified four DNA methylation-based subgroups of CRC have important clinical and therapeutic merit. Since genome-wide DNA methylation analyzes result in a large amount of data, there is a need for complex bioinformatic and pathway analysis. Future challenges in epigenetic alterations of CRC include the demand for comprehensive identification and experimental validation of gene abnormalities. By introduction of genome-wide DNA methylation profiling into clinical practice not only the patients' risk stratification but development of targeted therapies will also be possible.

AB - DNA methylation analysis methods have undergone an impressive revolution over the past 15 years. Regarding colorectal cancer (CRC), the localization and distribution of several differently methylated genes have been determined by genome-wide DNA methylation assays. These genes do not just influence the pathogenesis of CRC, but can be used further as diagnostic or prognostic markers. Moreover, the identified four DNA methylation-based subgroups of CRC have important clinical and therapeutic merit. Since genome-wide DNA methylation analyzes result in a large amount of data, there is a need for complex bioinformatic and pathway analysis. Future challenges in epigenetic alterations of CRC include the demand for comprehensive identification and experimental validation of gene abnormalities. By introduction of genome-wide DNA methylation profiling into clinical practice not only the patients' risk stratification but development of targeted therapies will also be possible.

KW - bisulfite treatment

KW - colorectal cancer

KW - epigenetics

KW - genome-wide DNA methylation

KW - next-generation sequencing

UR - http://www.scopus.com/inward/record.url?scp=84885008597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885008597&partnerID=8YFLogxK

U2 - 10.2217/epi.13.52

DO - 10.2217/epi.13.52

M3 - Article

VL - 5

SP - 569

EP - 581

JO - Epigenomics

JF - Epigenomics

SN - 1750-1911

IS - 5

ER -